| Value | ₹175.9 Cr |
|---|---|
| Execution period | One month |
NSE filing, NSE: RUBICON. Summary written from the filing by ALFA Finder's alert engine.
Rubicon Research Ltd: key numbers
- Share price
- ₹1,610.50
- Market cap
- ₹26,659 Cr
- Revenue (annual)
- ₹1,754 Cr
- Net profit (annual)
- ₹246.7 Cr
- P/E (TTM)
- 92.5×Sector 45.9×
- Promoter holding
- 51.25%-8.51% QoQ
- FII holding
- 9.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rubicon Research Ltd
All →Rubicon Research Business Update
Rubicon Research disclosed a USFDA inspection of its Ambernath facility, which issued five procedural Form 483 observations. No monetary penalty or amount is involved.
Rubicon Research Board Meeting Date
Rubicon Research scheduled its Board for November 5, 2026, to consider unaudited financial results for the half year ended September 2026. Trading window closed since October 1.
Rubicon Research Other Announcement
Rubicon Research Ltd filed its quarterly shareholding pattern for the quarter ended September 30, 2026, pursuant to Regulation 31(1)(b) of the LODR Regulations.
Rubicon Research Business Update
Rubicon Research reported the conclusion of a US FDA inspection at its Satara facility. The audit yielded one procedural observation unrelated to data integrity.
Rubicon Research Employee Stock Options
Rubicon Research allotted 7,200 equity shares under its Employee Stock Option Scheme 2022. This issuance marginally increases the company's total paid-up share capital.
Rubicon Research Capital Structure Change
Employee Girish Subramaniam Iyer sold 6,796 shares in the open market across four transactions for a total consideration of ₹1.23 Crore.
- Value
- ₹1.23 Cr
Other acquisition announcements
All →Arvaya Healthcare Acquisition
Arvaya Healthcare completed the acquisition of 100% equity in Sushodha Institute of Gastroenterology Private Limited on 1 November 2026. The target is now a wholly-owned subsidiary, with no consideration amount disclosed.
Affle 3I Acquisition Worth ₹3,990 Cr
Affle 3i's step-down subsidiary will acquire Perion Network in an all-cash deal valued at about ₹3,990 Crore. Closing is expected in early 2027.
- Value
- ₹3,990 Cr
- Execution
- Expected to close in early 2027
Sai Parenterals Acquisition
Sai Parenterals will acquire the remaining 25% stake in its 75% subsidiary SP Analytics for cash, making it wholly owned. Related-party approval was taken at the 1 November 2026 board meeting, with completion by 31 December 2026.
- Execution
- 31-12-2026
R R Kabel Acquisition Worth ₹77 Cr
R R Kabel completed its acquisition of U M Cables' optical fibre business via slump sale for Rs.77 Crore. The transaction took effect from 31 October 2026.
- Value
- ₹77.00 Cr
R R Kabel Acquisition
R R Kabel completed its acquisition of U M Cables' business undertaking via slump sale, effective 31 October 2026. No consideration amount was disclosed in this intimation.
JSW Steel Acquisition
JSW Steel's scheme to amalgamate Piombino Steel became effective on 31 October 2026. Piombino now stands merged into JSW Steel under the NCLT-sanctioned scheme.